risperidone has been researched along with sildenafil citrate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Aviv, A; Shelef, A; Weizman, A | 1 |
| Akhondzadeh, S; Esfandiari, GR; Ghayyoumi, R; Ghebleh, F; Maroufi, A; Modabbernia, AH; Naderi, M; Rezaei, F; Rezazadeh, SA; Salehi, B; Tabrizi, M | 1 |
| Kaushik, GN | 1 |
2 trial(s) available for risperidone and sildenafil citrate
| Article | Year |
|---|---|
An open-label trial of sildenafil addition in risperidone-treated male schizophrenia patients with erectile dysfunction.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Patient Compliance; Patient Satisfaction; Piperazines; Purines; Risperidone; Schizophrenia; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents | 2004 |
Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial.
Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Purines; Risperidone; Schizophrenia; Schizophrenic Psychology; Sildenafil Citrate; Sulfones; Young Adult | 2011 |
2 other study(ies) available for risperidone and sildenafil citrate
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Re: sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia.
Topics: Antipsychotic Agents; Humans; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Risperidone; Schizophrenia; Sildenafil Citrate; Sulfones | 2011 |